BioMatrix Healthcare Pvt. Ltd.
Established in the year 2007, with a thought of “Supporting Life Worldwide”. With headquarter at Ahmedabad, currently we are into 100% export business. We have committed ourselves to provide affordable and innovative healthcare globally.
Financial Growth
From last five years the company has posted robust growth of 33% CAGR. The company has achieved its first dream milestone of INR 1000 millions Annual Revenue in FY 2018-19.
Business Expansion
- Strong presence in 21 countries of Africa and CIS region
- Ongoing registrations in 10 countries of the Francophone region
Product Basket (Portfolio)
- 1000+ Products registration
- 450+ Products under registration
Manufacturing Facility
BioMatrix has State-of-the-Art Oral solids, Liquid and Dry syrup manufacturing facility with WHO-GMP, EU-GMP accreditation and US-FDA, UK-MHRA & ANVISA compliance.
With this State-of-the-Art manufacturing facility, BioMatrix will accelerate its growth in the existing international markets and shall expand its wings further across the globe.
Manufacturing Capacities:
- 5 Billion Tablets/Annum
- 1 Billion Capsules/Annum
- 24 Million Bottles of Liquid/Annum
- 18 Million Bottles of Dry syrup/Annum
Experience over the years
Vast experience of Management in Domestic & International Market had been the driving force that leads our team forward.
Domain Expertise
With decades of experience, the team has expertise to innovate and evolve customer driven marketing strategies to sustain market leading position in this competitive era.
Trust Of Customer & Associates
Extensive Experience, Core Competency & Strong Business Ethics has made BioMatrix earn trust of all its Customers & Associates.
Milestone
2007 - 2013
- Establishment of Biomatrix in a modest setup in Ahmedabad.
- Over 100 products registered!
2018
- A year of surpassing INR 100 million turnover, and also registering 250 products
2020
- Commissioned a state of the art, WHO-GMP compliant manufacturing facility
2022
- Commenced Operation in Francophone Countries
- 800+ Product Registrations
2023
- Accorded the status of 3 Star Export House
- Established Research and Development (R&D) Center to Develop Innovative Product & PRocess
Future Roadmap
2024
- UK-MHRA, TGA & Health Canada Approval for Manufacturing Plant
- To commence Operations in Europe, Central, South, and Latin America
2025
- To establish API Manufacturing Unit
- To commence Domestic Operations
2026
- Establishment of New Manufacturing Facility for Injectables
2027
- USFDA Approval for Manufaturing Plant
Our Global Reach
Certification
World Health Organisation-GMP
Europe-GMP
Medicines Control Authority of Zimbabwe
Ethiopian Food & Drug Authority
Tanzania Medicines and Medical Devices Authority
National Drug Authority UGANDA
Food and Drug Authority GHANA
Pharmacy & Poisons Board | KENYA
National Regulatory Authority for Medicines of Mozambique (ANARME)
Pharmacy and Medicines Regulatory Authority MALAWI
Congolese Pharmaceutical Regulatory Authority (ACOREP) - DR CONGO
Ministry of Health CAMBODIA
Ministry of Public Health & Population | YEMEN
Three Star Export
House
Why Choose Us
Certified
WHO-GMP, EU-GMP Manufacturing Facility
Compliance
US-FDA, UK-MHRA and ANVISA
Star
Three-Star Export House
15 +
Years of Experience
30 +
Countries we are present in
1000 +
Product Registrations
Latest News
CPHI Milan
Oct-2024
UDAAN
Jan - 2021
Under the UDAAN initiative, from last three years, we have organized many cultural activities for BioMatrixians with their families. This gives us opportunity to strengthen team bonding.
EFDA, Ethiopia
July - 2022
Our state-of-the-art manufacturing facility has been approved by EFDA, Ethiopia for Oral solid, Liquid and dry powder dosage formulations.
NDA,Uganda
Aug - 2022
It is an indeed proud moment for Biomatrix to achieve another successive approval for Oral solid, dry powder and liquid dosage formulation. With this continuous accreditation, we strive to develop world-class products and make them available worldwide.
Three Star Export House
OCT - 2023
This is a proud moment for us that we have been accorded the status of THREE STAR EXPORT HOUSE by the Directorate General of Foreign Trade in honour of our extraordinary export performance and significant contributions to the country's economy. We are incredibly proud of "Team BioMatrix" for achieving this significant milestone.
EU-GMP Approval
Aug-2024
